Clinical Characteristics of Telogen Effluvium Induced by COVID-19 Infection: Integrative Review

    January 2023 in “ Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida ”
    Raquel de Souza Mota, Alexandre Braga Gomes, Arthur Henrique Silva da Fonseca … Tereza Cristina dos Reis Ferreira
    Studysummary This study reviewed clinical literature on telogen effluvium caused by COVID-19 and found that intense hair shedding predominantly affected women, typically developing two months post-infection and resolving within one to four months.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on revista.cpaqv.org →
    Discuss this study in the Community →

    Research cited in this study 21

    1. Impact of Stem Cell-Based Therapy and Platelet-Rich Plasma in Hair Loss and Telogen Effluvium Related to COVID-19 Regenerative Therapy · 2023
    2. Post-Covid Telogen Effluvium PubMed · 2022
    3. Telogen Effluvium and COVID-19: A Case and a Brief Review of Literature Medicina · 2022
    4. Characteristics of Hair Loss After COVID-19: A Systematic Scoping Review Journal of Cosmetic Dermatology · 2022
    5. Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication Journal of Clinical Medicine · 2022
    6. Alopecia in Patients with COVID-19: A Systematic Review and Meta-Analysis JAAD International · 2022
    7. Pathological Sequelae of Long-Haul COVID Nature Immunology · 2022
    8. Red Nail Bands in Conjunction with Telogen Effluvium as a Post-COVID-19 Phenomenon Australasian Journal of Dermatology · 2021
    9. A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation Journal of Medical Virology · 2021
    10. Early-Onset Effluvium Secondary to COVID-19: Clinical and Histologic Characterization Journal of The American Academy of Dermatology · 2021
    11. COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium Irish Journal of Medical Science (1971 -) · 2021
    12. Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium Journal of The American Academy of Dermatology · 2021
    13. Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients Experimental Dermatology · 2021
    14. Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2 Revista da Sociedade Portuguesa de Dermatologia e Venereologia · 2021
    15. Telogen Effluvium Associated with COVID-19 Infection Dermatologic Therapy · 2021
    16. Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms Skin appendage disorders · 2021
    17. SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study Journal of the European Academy of Dermatology and Venereology · 2020
    18. Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience Dermatologic Therapy · 2020
    19. Acute Telogen Effluvium Associated with SARS-CoV-2 Infection AJGP · 2020
    20. Telogen Effluvium: A Review of the Literature Cureus · 2020
    21. Dihydrotestosterone-Inducible IL-6 Inhibits Elongation of Human Hair Shafts by Suppressing Matrix Cell Proliferation and Promotes Regression of Hair Follicles in Mice Journal of Investigative Dermatology · 2011